CSIMarket
 


Zynex inc   (ZYXI)
Other Ticker:  
 

Zynex Inc 's Total Debt to Equity

ZYXI's quarterly Total Debt to Equity and Total Debt, Equity growth


Due to net new borrowings of 0.4%, Total Debt to Equity fell to 1.25, a new company high.

Within Medical Equipment & Supplies industry in the forth quarter 2023, 63 other companies have achieved lower Total Debt to Equity than Zynex Inc in the IV Quarter 2023. While Total Debt to Equity total ranking has deteriorated compared to the third quarter 2023 from 784 to 1499 .

Explain Debt to Equity Ratio?
What is the structure of ZYXI´s Total Debt?
How valuable is the ZYXI´s Equity?


ZYXI Total Debt to Equity (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change -30.48 % -10.13 % -9.77 % -14.95 % -10.24 %
Y / Y Total Debt Change 442.11 % 379.96 % 330.32 % -36.37 % -33.33 %
Total Debt to Equity MRQ 1.25 0.98 0.92 0.14 0.16
ZYXI's Total Ranking # 1499 # 784 # 1401 # 710 # 400
Seq. Equity Change -21.26 % -5.92 % -3.44 % -2.82 % 1.8 %
Seq. Total Debt Change 0.4 % 0.38 % 514.77 % -12.51 % -11.11 %



Total Debt to Equity forth quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 64
Healthcare Sector # 161
Overall Market # 1499


Total Debt to Equity Statistics
High Average Low
1.25 0.28 0
(Dec 31 2023)   (Sep 30 2018)




Financial Statements
Zynex Inc 's Equity $ 46 Millions Visit ZYXI's Balance sheet
Zynex Inc 's Total Debt $ 58 Millions Visit ZYXI's Balance sheet
Source of ZYXI's Sales Visit ZYXI's Sales by Geography


Cumulative Zynex Inc 's Total Debt to Equity

ZYXI's Total Debt to Equity for the trailling 12 Months

ZYXI Total Debt to Equity

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth -30.48 % -10.13 % -9.77 % -14.95 % -10.24 %
Y / Y Total Debt TTM Growth 442.11 % 379.96 % 330.32 % -36.37 % -33.33 %
Total Debt to Equity TTM 0.78 0.53 0.34 0.17 0.18
Total Ranking TTM # 62 # 86 # 81 # 841 # 33
Seq. Equity TTM Growth -21.26 % -5.92 % -3.44 % -2.82 % 1.8 %
Seq. Total Debt TTM Growth 0.4 % 0.38 % 514.77 % -12.51 % -11.11 %


On the trailing twelve months basis Due to the net new borrowings of 0.4% during the trailing twelve months finishing in the IV Quarter 2023, cumulativeTotal Debt to Equity improved to 0.78, above the Zynex Inc 's average Total Debt to Equity.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry 2, during the past 12 months, other companies have achieved lower Total Debt to Equity than Zynex Inc . While Total Debt to Equity total ranking has improved so far to 62, from total ranking in previous 12 month period at 86.

Explain Debt to Equity Ratio?
What is the structure of ZYXI´s Total Debt?
How valuable is the ZYXI´s Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 3
Healthcare Sector # 16
Within the Market # 62


trailing twelve months Total Debt to Equity Statistics
High Average Low
0.94 0.23 0
(Dec 31 2017)   (Jun 30 2019)




Companies with similar Total Debt to Equity in the quarter ending Dec 31 2023, within Medical Equipment & Supplies Industry Total Debt to EquityDec 31 2023 MRQ Total DebtDec 31 2023 MRQ Equity
3m Company  3.29 $ 16,035.000  Millions$ 4,868.000  Millions
Owens and Minor inc  2.27 $ 2,097.502  Millions$ 924.166  Millions
Tela Bio Inc   2.15 $ 40.515  Millions$ 18.881  Millions
Insulet Corporation  1.93 $ 1,415.800  Millions$ 732.700  Millions
Bioventus Inc   1.79 $ 394.846  Millions$ 221.118  Millions
Neuronetics inc   1.73 $ 59.283  Millions$ 34.190  Millions
Baxter International Inc   1.63 $ 13,798.000  Millions$ 8,468.000  Millions
Novocure Limited  1.57 $ 568.822  Millions$ 362.496  Millions
Zynex inc   1.25 $ 57.605  Millions$ 46.129  Millions
Apyx Medical Corporation  1.23 $ 33.185  Millions$ 26.922  Millions
Dexcom Inc   1.18 $ 2,434.200  Millions$ 2,068.600  Millions
Conmed Corporation  1.17 $ 973.848  Millions$ 834.222  Millions
Shockwave Medical Inc   1.09 $ 731.863  Millions$ 668.677  Millions
Artivion Inc   1.09 $ 306.982  Millions$ 281.780  Millions
Haemonetics Corporation  0.92 $ 870.585  Millions$ 943.319  Millions
Tandem Diabetes Care Inc   0.91 $ 285.035  Millions$ 313.632  Millions
Integra Lifesciences Holdings Corp  0.89 $ 1,410.349  Millions$ 1,587.884  Millions
Icu Medical Inc  0.77 $ 1,628.770  Millions$ 2,123.410  Millions
Medinotec Inc   0.76 $ 1.581  Millions$ 2.075  Millions
Cadre Holdings Inc   0.71 $ 140.132  Millions$ 197.162  Millions
Merit Medical Systems Inc  0.68 $ 823.013  Millions$ 1,202.000  Millions
Bausch and Lomb Corp  0.66 $ 4,562.000  Millions$ 6,920.000  Millions
Masimo Corp  0.64 $ 871.700  Millions$ 1,364.800  Millions
Integer Holdings Corporation  0.63 $ 959.925  Millions$ 1,519.042  Millions
Msa Safety Incorporated  0.62 $ 601.692  Millions$ 966.802  Millions
Beyond Air Inc   0.62 $ 14.510  Millions$ 23.471  Millions
Glaukos Corp  0.61 $ 282.773  Millions$ 461.766  Millions
National Vision Holdings Inc   0.56 $ 461.251  Millions$ 829.418  Millions
Henry Schein Inc  0.55 $ 2,351.000  Millions$ 4,289.000  Millions
Steris Plc  0.51 $ 3,309.513  Millions$ 6,428.099  Millions

Date modified: 2024-03-13T04:00:45+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com